Gait analysis following single-shot hyaluronic acid supplementation: a pilot randomized double-blinded controlled trial

Abstract

Objectives Viscosupplementation with new-generation, polyol-containing, cross-linked hyaluronic acid (HA) gels reduces joint inflammation in patients with knee osteoarthritis. Gait analysis is a complementary outcome measure to standard patient-reported scores and physical measures for testing the effect of HA injection. This three-arm, prospective, randomized, controlled, double-blind, feasibility pilot study investigated which gait parameters are more sensitive following a single bolus injection of polyol-containing HA for knee osteoarthritis. Methods Twenty-two patients with Ahlbäck grade II–III knee osteoarthritis were randomly allocated into three groups: (1) HA + mannitol ( n = 9), (2) HA + sorbitol ( n = 5), and (3) saline placebo ( n = 8). Patients were assessed by blinded observers prior to injection and at 4 weeks post-injection (4W). Outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee Society score (KSS), EuroQol in five-dimensions (EQ-5D), VAS pain, and VAS stiffness. Gait was assessed over 30 m using a portable inertial-based data logger (Physilog®). Results Differences between 4W and baseline were statistically significant for the mannitol-containing viscosupplement, with a median increase of 0.076 m/s on gait speed ( p = 0.039), 0.055 m on stride length ( p = 0.027), and 15 points on the KSS ( p = 0.047). In contrast, the HA + sorbitol and saline groups demonstrated no significant changes from baseline to 4W in any gait parameters or self-reported outcome measures (all p > 0.3). The observed increase in gait speed is approximately 13% greater than the mean difference between healthy subjects and those with knee osteoarthritis, is clinically important, and thus is a sensitive gait parameter. Conclusions This study demonstrated gait speed and stride length are the most relevant gait parameters to investigate when assessing the effect of polyol-containing HA viscosupplementation. This study supports the need for a larger, randomized, controlled, clinical trial to assess the effect of a single-bolus HA injection versus multiple injections in people with knee osteoarthritis using both gait performance and self-reported parameters of knee function. Trial registration This study was retrospectively registered at clinicaltrials.gov on August 20, 2018, and assigned # NCT03636971 . Level of evidence I

Electrospun tube reduces adhesion in rabbit Achilles tendon 12 weeks post-surgery without PAR-2 overexpression

“…Up to date, pharmacological strategies have been used, such as hyaluronic acid that acts like a lubricant and enables better gliding [12][13][14][15] or 5-fluorouracil that blocks fibro-osseous fibroblast proliferation, associated with OPEN 1 Division of Plastic Surgery and Hand Surgery, University Hospital Zurich, ZKF, Sternwartstrasse 14, 8091 Zurich, Switzerland. 2 Laboratory of Applied Mechanobiology, ETH Zürich, Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland.…”

Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis

“…Few prospective intervention studies have reported the impact of pharmacologic treatment compared with placebo on EQ-5D in patients with OA [ 28 , 29 ]. Studies of tapentadol and oxycodone have reported inconsistent benefits on EQ-5D index value [ 30 – 32 ], and there was no improvement from baseline in EQ VAS following a single injection of hyaluronic acid for OA [ 33 ].…”

In Vitro Assessment of Bacterial Adhesion and Biofilm Formation on Novel Bioactive, Biodegradable Electrospun Fiber Meshes Intended to Support Tendon Rupture Repair

“…1 Moreover, due to scar formation and fibrosis, the healing tendon tissue is of inferior mechanical stability as compared to the native healthy tissue and is therefore prone to rerupture when loaded. 2 Different approaches have been used to counteract these problems, such as administration of hyaluronic acid as a lubricant, 3,4 5-fluorouracil to block fibroosseous fibroblast proliferation associated with extrinsic tendon healing 5 or anti-inflammatory drugs like ibuprofen, that showed to be a good antiadhesion agent thanks to the inhibition of cyclooxygenases-1 and −2. 6 In addition, novel implant materials to address these two major problems are currently being developed.…”